Smartest Doc
U.S. approval for Natazia to treat heavy menstrual bleeding Full Text
BayNews International,
The U.S. Food and Drug Administration (FDA) has approved the Bayer contraceptive Natazia for the treatment of heavy menstrual bleeding that is not caused by any diagnosed conditions of the uterus in women who choose to use an oral contraceptive for contraception. Natazia is the first combined oral contraceptive indicated for the treatment of heavy menstrual bleeding in the United States. "Heavy menstrual bleeding is a medical condition in which bleeding is excessive enough to interfere with a woman's lifestyle and daily activities," said Dr. Flemming Ornskov, Head of Strategic Marketing in General Medicine at Bayer HealthCare Pharmaceuticals.
